News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Hepatitis and HIV
Hepatitis C does not raise risk of heart disease or cancers in people with HIV

Hepatitis C coinfection does not increase the risk of cardiovascular disease or non-AIDS cancers in people with HIV, an analysis of the large Eurosida cohort published in

Published
19 July 2019
By
Keith Alcorn
Access to medicines and treatment
Desperate patients turn to buyers clubs

What do you do when the NHS won’t buy the treatment you need?

Published
25 June 2019
From
The Economist (free registration required)
Hepatitis and HIV
Just 18% of people with hepatitis/HIV co-infection and cirrhosis are screened for liver cancer as often as recommended

There is a “strikingly low adherence” to clinical guidelines for ultrasound screening for hepatocellular carcinoma in western Europe, researchers report in the Journal of Viral Hepatitis.Over years

Published
10 June 2019
By
Roger Pebody
Hepatitis C transmission and prevention
Hepatitis C more stigmatising than HIV: gay men’s attitudes towards hepatitis C reinfection

Qualitative research with HIV-positive gay and bisexual men in Australia who had been cured of hepatitis C infection revealed that having hepatitis C was more stigmatising than

Published
04 June 2019
By
Krishen Samuel
Side-effects
Preventing Drug Induced Liver Injury in Patients with HIV

With an estimated annual incidence rate of 13.9 to 24 per 100,000 inhabitants, drug-induced liver injury (DILI) the leading cause of acute liver failure in the United States. It is also a unique concern in people living with HIV. Recognizing the importance of comorbid HIV and DILI, researchers from Sacco University Hospital in Milano, Italy, have published a comprehensive review of the topic ahead-of-print in the journal Pharmacological Research.

Published
03 June 2019
From
Pharmacy Times
Vaccinations and immunisations
HIV-Related Factors Predict Reinforced Hepatitis B Vaccination Success

Certain characteristics and HIV-related factors may help predict whether certain demographics of people with HIV will have an optimal response to reinforced hepatitis B virus vaccination, according to an article published in Vaccine.

Published
03 June 2019
From
Infectious Disease Advisor
Retention and linkage to care
Cash Incentives, Peer Support May Not Incentivize HCV Treatment

A randomized trial comparing a cash incentive to peer support for increasing acceptance of treatment for hepatitis C virus (HCV) among persons with HCV/HIV coinfection, including those who use drugs or alcohol, found both methods helpful but that 1 in 4 patients still declined treatment.

Published
10 May 2019
From
MD Magazine
Elimination of hepatitis C
NHS trumpets Hep C deal, quietly drops 2025 elimination target after legal row

NHS England has announced a deal with AbbVie, Gilead, and Merck, Sharpe and Dohme (MSD) that aims to eliminate hepatitis C from the country – although it has had to drop a 2025 target date because of a legal row during the procurement process.

Published
30 April 2019
From
pharmaphorum
Elimination of hepatitis C
NHS England strikes world leading deal to help eliminate hepatitis C

The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could help England become the first country in the world to eliminate the deadly virus.

Published
30 April 2019
From
NHS England
Hepatitis and HIV
Fatty liver disease a rising cause of liver problems in people with HIV

Now that hepatitis C can be successfully treated, non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly important cause of serious liver problems and liver-related death among people

Published
24 April 2019
By
Liz Highleyman
← First12345...246Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.